Based on further analysis of the human PPI network, we found that CCL5, CXCL10, CXCR2, and IL2 interacted with 54 proteins in the human PPI network to regulate other therapeutic targets of RA, as shown in Figure 9. This evidence concerns the gene IL2 and rheumatoid arthritis.